Klaria Pharma Holding Overview

  • Founded
  • 2015
Founded
  • Status
  • Public
  • Employees
  • 6
Employees
  • Stock Symbol
  • KLAR
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $0.70
  • (As of Tuesday Closing)

Klaria Pharma Holding General Information

Description

Klaria Pharma Holding AB is engaged in the development and commercialization of pharmaceutical products in Sweden for migraine and cancer-related pain. Its operations are based on a patented drug delivery platform in the form of an alginate-based polymer film.

Contact Information

Website
Formerly Known As
Annodam AB
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Stock Exchange
STO
Primary Office
  • Virdings Allé 2
  • 754 50 Uppsala
  • Sweden
+46 08-446 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Klaria Pharma Holding Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.70 $0.71 $0.28 - $1.06 $36.2M 51.8M 250K -$0.13

Klaria Pharma Holding Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 37,008 37,008 13,989 31,973
Revenue 0 0 446 0
EBITDA (3,841) (3,841) (1,169) (2,039)
Net Income (5,579) (5,579) (2,378) (3,138)
Total Assets 16,141 16,141 10,880 11,821
Total Debt 1,251 1,251 1,152 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Klaria Pharma Holding Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Klaria Pharma Holding‘s full profile, request access.

Request a free trial

Klaria Pharma Holding Executive Team (4)

Name Title Board Seat Contact Info
Leif Ingemarsson Chief Technology Officer
Jesper Wiklund Chief Executive Officer
Hans Richter Chief Financial Officer
Scott Boyer Chief Scientific Officer
To view Klaria Pharma Holding’s complete executive team members history, request access »

Klaria Pharma Holding Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Klaria Pharma Holding Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 000000 000 06-Mar-2020 000000000000000000 000 Drug Discovery 00000 00000
00000000000000 000 05-Nov-2019 000000000000000000 Drug Delivery 00000 00000
WBC Technologies 19-Sep-2019 Merger of Equals Discovery Tools (Healthcare) 00000 00000
To view Klaria Pharma Holding’s complete acquisitions history, request access »

Klaria Pharma Holding Subsidiaries (1)

Company Name Industry Location Founded
0000000 000000 000 Drug Discovery Taby, Sweden 0000
To view Klaria Pharma Holding’s complete subsidiaries history, request access »